2026-01-27 - Analysis Report
# Intuitive Surgical (ISRG) Analysis

## Overview
Intuitive Surgical is a medical technology company that develops and manufactures robots for minimally invasive procedures.

## Comparison with S&P 500 (VOO)
### Return Rate
- Review Ticker (ISRG): 202.48%
- Comparison Ticker (VOO): 127.58%
- Divergence (last day of data): 74.90%

## 5-Year Alpha, Beta Analysis
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|--------|
| 2016-2018  | 66.0% | 21.8% | 57.0% | 1.2  | 57.2B  |
| 2017-2019  | 73.0% | 21.8% | 48.0% | 1.4  | 70.6B  |
| 2018-2020  | 54.0% | 39.7% | 30.0% | 1.2  | 97.8B  |
| 2019-2021  | 89.0% | 39.7% | 25.0% | 1.2  | 128.8B |
| 2020-2022  | 13.0% | 45.7% | 8.0%  | 1.2  | 95.1B  |
| 2021-2023  | 12.0% | 45.7% | -6.0% | 1.4  | 120.9B |
| 2022-2024  | 107.0% | 36.7% | 78.0% | 1.3  | 187.1B |
| 2023-2025  | 152.0% | 27.8% | 77.0% | 1.2  | 203.0B |

## Recent Stock Price Fluctuations
- Close: $528.81
- Last-market:
  - Last: $528.81
  - Previous Close: $523.99
  - Change: $4.82 (0.92%)
- 5-day SMA: $525.95
- 20-day SMA: $558.22
- 60-day SMA: $559.46

## RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence
- Market Risk Indicator (MRI): 0.70
- RSI: 32.40
- PPO: -0.99
- Hybrid Signal: Buy (Cash 0%)
- Risk Level: Medium (MRI 0.70)
- Recent (20 days) relative divergence change: -5.10
- 7-day Rank change: 44
- 7-day Dynamic Expected Return change: 62.00
- Expected Return (%): 70.30%

## Recent News & Significant Events
- [2026-01-23] Why This Robotics Giant's Lackluster Guidance Isn't All Doom - Investor's Business Daily
- [2026-01-23] ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines - Yahoo Finance
- [2026-01-23] More Upside For ISRG Stock? - Forbes
- [2026-01-23] ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines - Zacks Investment Research
- [2026-01-26] Intuitive Surgical, Inc. $ISRG Shares Sold by Mutual of America Capital Management LLC - MarketBeat
- [2026-01-26] Robot heart surgery gets boost as FDA clears da Vinci 5 system - Stock Titan

## Analyst Opinions
- Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 2.06 (~Buy)
  - Opinions: 30
  - Target Price (avg/high/low): 608.55 / 750.00 / 378.00

## Recent Earnings Analysis
| Date | EPS | Revenue |
|-----|-----|---------|
| 2025-10-22 | 1.98 | 2.51 B$ |
| 2025-07-23 | 1.84 | 2.44 B$ |
| 2025-04-23 | 1.95 | 2.25 B$ |
| 2024-10-18 | 1.59 | 2.04 B$ |
| 2025-10-22 | 1.59 | 2.04 B$ |

## Revenue and Profitability
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $2.51B | 66.36% |
| 2025-06-30 | $2.44B | 66.31% |
| 2025-03-31 | $2.25B | 64.69% |
| 2024-12-31 | $2.41B | 68.04% |

## Capital and Profitability
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $16.93B | 4.16% |
| 2025-06-30 | $17.85B | 3.69% |
| 2025-03-31 | $17.11B | 4.08% |
| 2024-12-31 | $16.43B | 4.17% |

## Comprehensive Analysis
Based on the review of the provided data, we can conclude the following:
- Intuitive Surgical (ISRG) has shown significant growth in its return rate, outperforming the S&P 500 (VOO).
- The company's 5-year Alpha, Beta analysis shows mixed results, with periods of high growth and volatility.
- Recent stock price fluctuations show a sharp rebound, indicating a positive trend.
- RSI, PPO index indicators, and Delta_Previous_Relative_Divergence suggest a medium risk level, with a Hybrid Signal recommending a buy.
- Recent news and significant events indicate positive developments, such as the FDA clearing the da Vinci 5 system.
- Analyst opinions suggest a buy recommendation, with a target price of 608.55.
- Recent earnings analysis shows mixed results, with periods of high growth and revenue beat.
- Financial information indicates a significant increase in revenue and profit margin, with a high return on equity.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.